These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 9863713)
1. Development of a method to separate lipoprotein-bound and lipoprotein-depleted tissue factor pathway inhibitor. Measurement of free tissue factor pathway inhibitor activity. Bridey F; Lacombe C; Sustendal L; Moatti D; Combe F; Mammès O; de Prost D Blood Coagul Fibrinolysis; 1998 Oct; 9(7):637-43. PubMed ID: 9863713 [TBL] [Abstract][Full Text] [Related]
2. Tissue factor pathway inhibitor with high anticoagulant activity is increased in post-heparin plasma and in plasma from cancer patients. Lindahl AK; Jacobsen PB; Sandset PM; Abildgaard U Blood Coagul Fibrinolysis; 1991 Dec; 2(6):713-21. PubMed ID: 1799658 [TBL] [Abstract][Full Text] [Related]
3. Evidence that the C-terminus of tissue factor pathway inhibitor (TFPI) is essential for its in vitro and in vivo interaction with lipoproteins. Valentin S; Nordfang O; Bregengård C; Wildgoose P Blood Coagul Fibrinolysis; 1993 Oct; 4(5):713-20. PubMed ID: 8292720 [TBL] [Abstract][Full Text] [Related]
4. Measurement of tissue factor pathway inhibitor in normal and post-heparin plasma. Hubbard AR; Weller LJ; Gray E Blood Coagul Fibrinolysis; 1994 Oct; 5(5):819-23. PubMed ID: 7865689 [TBL] [Abstract][Full Text] [Related]
6. Tissue factor pathway inhibitor in complex with low density lipoprotein isolated from human plasma does not possess anticoagulant function in tissue factor-induced coagulation in vitro. Hansen JB; Huseby KR; Huseby NE; Ezban M; Nordøy A Thromb Res; 1997 Mar; 85(5):413-25. PubMed ID: 9076898 [TBL] [Abstract][Full Text] [Related]
7. Partial depletion of tissue factor pathway inhibitor during subcutaneous administration of unfractionated heparin, but not with two low molecular weight heparins. Bendz B; Hansen JB; Andersen TO; Ostergaard P; Sandset PM Br J Haematol; 1999 Dec; 107(4):756-62. PubMed ID: 10606880 [TBL] [Abstract][Full Text] [Related]
8. The present status of tissue factor pathway inhibitor. Lindahl AK; Sandset PM; Abildgaard U Blood Coagul Fibrinolysis; 1992 Aug; 3(4):439-49. PubMed ID: 1420819 [TBL] [Abstract][Full Text] [Related]
10. Enhancement of lipoprotein lipase activity by tissue factor pathway inhibitor. Mukherjee M; Kakkar VV Thromb Haemost; 1999 Dec; 82(6):1648-51. PubMed ID: 10613650 [TBL] [Abstract][Full Text] [Related]
11. Molecular weight-dependent influence of heparin on the form of tissue factor pathway inhibitor circulating in plasma. Alban S Semin Thromb Hemost; 2001 Oct; 27(5):503-11. PubMed ID: 11668420 [TBL] [Abstract][Full Text] [Related]
12. Tissue-factor pathway inhibitor and lipoproteins. Evidence for association with and regulation by LDL in human plasma. Hansen JB; Huseby NE; Sandset PM; Svensson B; Lyngmo V; Nordøy A Arterioscler Thromb; 1994 Feb; 14(2):223-9. PubMed ID: 8305412 [TBL] [Abstract][Full Text] [Related]
13. Differential effect of unfractionated heparin and low molecular weight heparin on intravascular tissue factor pathway inhibitor: evidence for a difference in antithrombotic action. Hansen JB; Sandset PM; Huseby KR; Huseby NE; Bendz B; Ostergaard P; Nordøy A Br J Haematol; 1998 Jun; 101(4):638-46. PubMed ID: 9674734 [TBL] [Abstract][Full Text] [Related]
14. Tissue factor pathway inhibitor is expressed by human monocyte-derived macrophages : relationship to tissue factor induction by cholesterol and oxidized LDL. Petit L; Lesnik P; Dachet C; Moreau M; Chapman MJ Arterioscler Thromb Vasc Biol; 1999 Feb; 19(2):309-15. PubMed ID: 9974412 [TBL] [Abstract][Full Text] [Related]
15. [Chromogenic assay for functional determination of TFP]. Alban S Hamostaseologie; 2005 Aug; 25(3):286-92. PubMed ID: 16113753 [TBL] [Abstract][Full Text] [Related]